dextrothyroxine has been researched along with Allergic Encephalomyelitis in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Jin, C; Liu, W; Sang, H; Wang, J; Xie, Y | 1 |
Capetillo-Zarate, E; Domercq, M; Gejo, J; Koch-Nolte, F; Llop, J; Lukowiak, M; Magnus, T; Martin, A; Matute, C; Palomino, A; Perez-SamartÃn, A; Pulagam, KR; Rassendren, F; Rissiek, B; Vazquez-Villoldo, N; Zabala, A | 1 |
2 other study(ies) available for dextrothyroxine and Allergic Encephalomyelitis
Article | Year |
---|---|
Ivermectin Protects Against Experimental Autoimmune Encephalomyelitis in Mice by Modulating the Th17/Treg Balance Involved in the IL-2/STAT5 Pathway.
Topics: Animals; CD8-Positive T-Lymphocytes; Encephalomyelitis, Autoimmune, Experimental; Interleukin-17; Interleukin-2; Ivermectin; Mice; Mice, Inbred C57BL; Multiple Sclerosis; STAT5 Transcription Factor; T-Lymphocytes, Regulatory; Th17 Cells | 2023 |
P2X4 receptor controls microglia activation and favors remyelination in autoimmune encephalitis.
Topics: Adenosine Triphosphate; Animals; Encephalomyelitis, Autoimmune, Experimental; Female; Gene Expression; Inflammation; Ivermectin; Macrophages; Mice; Microglia; Myelin Sheath; Oligodendroglia; Phagocytosis; Purinergic P2X Receptor Antagonists; Rats; Receptors, Purinergic P2X4; Remyelination | 2018 |